Threat actors are operationalizing AI to scale and sustain malicious activity, accelerating tradecraft and increasing risk for defenders, as illustrated by recent activity from North Korean groups ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...